Saturday 17 October 2026 Export ABCL’s income statement to Excel — free account

AbCellera Biologics Inc.

AbCellera Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.1 million, up 160.6% from fiscal 2024. In the quarter to June 2026, revenue fell 76.3%, EPS fell 50.0% and free cash flow grew 152.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.80 0.88 −6.94%

Follow ABCL

Alert me

Market cap: $4.1B
P/E: 0.0×
Fwd P/E: −8.7×
Dividend yield: —
F-score: 5/9
Altman Z: 1.66
Beneish M: −1.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	36.25	13.35	13.60	42.56
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	92.53	(31.55)	(29.40)	(28.58)
P/B ratio Full definition →	2.68	1.13	1.06	1.56
Price to Tangible BV Full definition →	2.96	1.24	1.16	1.71
EV/Sales Full definition →	27.76	6.71	6.21	27.92
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(19.35)	(3.47)	(3.55)	(9.43)
EV/FCF Full definition →	(14.96)	(2.76)	(2.63)	(6.31)
Quick Ratio Full definition →	10.97	11.98	9.60	8.17
Current Ratio Full definition →	12.77	14.05	11.32	10.10
Net Debt/EBITDA Full definition →	10.47	10.84	27.05	7.54
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.05	0.06	0.06	0.03
Operating CF/Net income Full definition →	(0.47)	0.78	3.88	0.92
Capex/Depreciation Full definition →	(0.24)	(0.44)	(1.24)	(1.23)
Research and Development Expense of Revenue Full definition →	1,135.48%	561.18%	111.68%	614.49%
Selling, General and Administrative Expense of Revenue Full definition →	341.98%	148.33%	38.39%	278.70%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.06	0.06
Share Based Compensation of Revenue Full definition →	303.36%	144.47%	28.77%	155.16%
Graham Net Nets Full definition →	0.11	0.28	0.33	0.20
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(6.88%)	(13.75%)	(14.33%)	(11.33%)
Free Cash Flow Yield Full definition →	(5.12%)	(18.19%)	(17.34%)	(10.39%)
Revenue per Share Full definition →	0.01	0.03	0.15	0.03
Operating CF per Share Full definition →	0.08	(0.11)	(0.12)	(0.18)
Capex per Share Full definition →	(0.01)	(0.01)	(0.03)	(0.03)
Free Cash Flow per Share Full definition →	0.08	(0.12)	(0.15)	(0.21)
Cash per Share Full definition →	1.85	1.75	1.87	1.74
Shareholders Equity per Share Full definition →	2.93	3.10	3.24	3.23
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.93	3.10	3.24	3.23
Free Cash Flow Full definition →	23.79	(37.35)	(44.59)	(61.52)
Working Capital Full definition →	626.04	617.30	663.93	626.34
Capital Expenditures Full definition →	(2.13)	(3.83)	(9.84)	(8.93)
Net Current Asset Value Full definition →	267.68	295.57	338.19	303.19
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.53	0.46	0.22	1.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	32.95	38.38	45.95	36.41
Average Payables Full definition →	41.28	43.70	52.89	53.45
Average Assets Full definition →	1,354.82	1,325.66	1,358.75	1,374.41
Average Common Equity Full definition →	951.55	980.53	1,011.49	1,021.07

Fold the line items

Columns are period end dates

Stockrow Weekly